ArticleNature communications2024
Dual heterogeneous interfaces enhance X-ray excited persistent luminescence for low-dose 3D imaging.
Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Triple Matrix Confinement-Induced Ultrabright Afterglow From Carbon Dots With Multivariate Responsive Afterglow Colors for Advanced Dynamic Information Encryption.Angewandte Chemie (International ed. in English) · 2026Article
- High-Security X-Ray Imaging Encryption Based on Irreversible Acid-Responsive Radioluminescence Memory Scintillator.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Low Afterglow Composite Scintillator for Real-Time X-Ray Imaging.Materials (Basel, Switzerland) · 2026Article
- Efficient multicolor X-ray excited persistent luminescence enabled by Gd-mediated trap clusters.Nature communications · 2026Article
- Multi-stimulated far-UVC luminescence for solar-blind imaging.Nature communications · 2025Article
- Controlled Synthesis of CsNanomaterials (Basel, Switzerland) · 2025Article
- Flexible X-Ray Detector for Cumulative Dose Monitoring Through Reversible Photochromism and Luminescence Modulation.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
- Trap Assisted Dynamic Mechanoluminescence Toward Self-Referencing and Visualized Strain Sensing.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Lanthanide-doped fluoride nanoparticles (NPs) showcase adjustable X-ray-excited persistent luminescence (XEPL), holding significant promise for applications in three-dimensional (3D) imaging through the creation of flexible X-ray detectors. However, a dangerous high X-ray irradiation dose rate and complicated heating procedure are required to generate efficient XEPL for high-resolution 3D imaging, which is attributed to a lack of strategies to significantly enhance the XEPL intensity. Here we report that the XEPL intensity of a series of lanthanide activators (Dy, Pr, Er, Tm, Gd, Tb) is greatly improved by constructing dual heterogeneous interfaces in a double-shell nanostructure. Mechanistic studies indicate that the employed core@shell@shell structure could not only passivate the surface quenchers to lower the non-radiative relaxation possibility, but also reduce the interfacial Frenkel defect formation energy leading to increase the trap concentration. By employing a NPs containing flexible film as the scintillation screen, the inside 3D electrical structure of a watch was clearly achieved based on the delayed XEPL imaging and 3D reconstruction procedure. We foresee that these findings will promote the development of advanced X-ray activated persistent fluoride NPs and offer opportunities for safer and more efficient X-ray imaging techniques in a number of scientific and practical areas.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.